Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (unaudited)

v3.10.0.1
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (16,690) $ (9,427)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 106 42
Revaluation of contingent royalty obligation 244 206
Share based compensation 1,735 1,894
Amortization of bond premium 15
Warrant expense 3,156
Inventory write-down 574
Changes in operating assets and liabilities:    
Accounts receivable (18) (1)
Inventory (614) (376)
Prepaid expenses and other current assets (74) (126)
Other long-term assets (255)
Accounts payable and accrued expenses 1,141 364
Other current and long-term liabilities (108) 61
Net cash used in operating activities (10,533) (7,618)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of fixed assets (194) (656)
Proceeds from (repayment of) long-term deposits 11 (24)
Repayment of shareholder loan receivable 126
Purchase of available-for-sale securities (5,026)
Proceeds from sale of available-for-sale securities 2,000
Purchase of held-to-maturity securities (4,863)
Proceeds from maturity of held-to-maturity securities 3,130
Net cash used in investing activities (4,816) (680)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from public offering, net of broker commissions of $1,400 16,100
Payments of public offering costs (1,109)
Proceeds from exercise of options, net of broker commissions of $22 306
Proceeds from issuance of shares, net of financing cost of $851 6,474
Net cash provided by financing activities 15,297 6,474
NET DECREASE IN CASH AND CASH EQUIVALENTS (52) (1,824)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 6,939 [1] 11,651
CASH AND CASH EQUIVALENTS AT END OF PERIOD 6,887 9,827
CASH PAID FOR:    
Interest
Income taxes
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:    
Reclassification of deferred financing fees from current assets to common stock 602
Cashless exercise of options 2
Deferred financing fees included in accounts payable and accrued expenses $ 59
[1] Derived from audited consolidated financial statements